Find and Pitch Jounalists, Get Your Story Covered

Tags: cancer metformin myeloid leukemia burn scars marjolin's ulcer

	Profile	Recent Articles on Subject
1	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests - about 1 month ago Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 3 months ago Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 6 months ago HIFU Non-Inferior to Prostatectomy for Localized Prostate Cancer - 8 months ago Francis Collins Discloses His 'Aggressive' Prostate Cancer Diagnosis - 9 months ago PSA and Biomarker Testing Plus MRI Appears to Improve Prostate Cancer Screening - 9 months ago Cabozantinib Plus Atezolizumab Delays Progression in mCRPC - 11 months ago Olaparib-Abiraterone in Biomarker-Selected mCRPC Tops Each Agent Alone - 11 months ago Two Million Cancers; Casgevy OK'd for Thalassemia; Rectal Exams and Prostate Cancer - 11 months ago Futile Immunotherapy for Cancer Grows More Common - 12 months ago TULSA Effective in Controlling Prostate Cancer Long-Term - about 1 year ago First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Response - about 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - about 1 year ago Multi-Agent Treatment Offers Hope in Advanced or Recurrent Endometrial Cancer - about 1 year ago Can ctDNA Guide Radiation Use in Oligometastatic NSCLC? - about 1 year ago
2	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	MHRA grants approval for bladder cancer drug erdafitinib - about 2 months ago ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study - 3 months ago
3	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Sequencing in Advanced Urothelial Carcinoma - about 2 months ago TIL Therapy May Offer Novel Approach for Metastatic Lung Cancer - 6 months ago Cabozantinib Plus Atezolizumab Improves PFS in Metastatic CRPC - 10 months ago Novel Prostate Cancer Screening Method Could Prevent Unnecessary Biopsies - 11 months ago Exercise Improved Quality of Life for Metastatic Breast Cancer Patients - 12 months ago Dato-DXd More Effective, Tolerable Than Chemo for Metastatic Breast Cancer - 12 months ago Financial Toxicity Among Single Mothers With Metastatic Breast Cancer - 12 months ago
4	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Incyte’s checkpoint inhibitor staves off disease progression in anal cancer trial - 3 months ago STAT+: Results on Novartis prostate cancer therapy could expand its use - about 1 year ago STAT+: Breast cancer drug from AstraZeneca, Daiichi hits goal in late-stage trial - over 1 year ago
5	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Local Therapy Developments Hold Promise for Survival Improvements for NSCLC - 3 months ago FDA Approves Enzalutamide for Nonmetastatic Castration-Sensitive Prostate Cancer - about 1 year ago
6	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Ahead of ASCO, J&J reports mixed data on next-generation radiopharmaceutical - 7 months ago
7	AFP Science Alert Science news. Official account. Australia science news	Scientists Predict Prostate Cancer Cases to Double Within 20 Years - 9 months ago
8	Clare Wilson New Scientist Science news source. Worldwide sciencenewstechnology	Could an MRI scan make prostate cancer screening more accurate? - 9 months ago
9	<em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	New Research Avenues Provide Hope for Metastatic Disease - 9 months ago
10	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Phase 3 EVOKE-01 Study in Metastatic NSCLC Falls Short of Primary Endpoint - 10 months ago FDA Approves Pembrolizumab Plus Chemotherapy to Treat Metastatic HER2-Negative Gastric, Gastroesophageal Junction Adenocarcinoma - about 1 year ago

Journalists covering metastatic prostate cancer